Evestia Clinical

Evestia Clinical is a privately held, specialist Contract Research Organization (CRO) that provides comprehensive clinical trial services to biotechnology and pharmaceutical clients globally. Founded in 2018, the company has grown organically and through acquisition, notably enhancing its capabilities by acquiring ICRC-Weyer. It differentiates itself by focusing on complex therapeutic areas and offering a personalized, agile partnership model rather than competing on scale alone, aiming to guide biotechs through critical development decisions.

Integrated clinical trial service delivery model with expertise in complex therapeutic areas. Offers full-service and Functional Service Provider (FSP) solutions, leveraging standard industry technology (CTMS, EDC) applied by specialized teams.

Competes in a fragmented CRO market dominated by large players (e.g., IQVIA, ICON) but differentiates as a specialist focusing on complex diseases and personalized partnership for biotechs. Competes with other mid-sized and niche CROs that also offer therapeutic area expertise and flexible engagement models.